002873 Guiyang Xintian Pharmaceutical
- 9.16
- -0.06-0.65%
Guiyang Xintian Pharmaceutical News
Xintian Pharmaceutical: 2024 Interim Equity Distribution Implementation Notice
Xintian Pharmaceutical: Announcement on shareholders\' cancellation of share pledges
Xintian Pharmaceutical: Announcement on the 2024 Mid-Term Profit Distribution Plan
Xintian Pharmaceutical: Announcement on the extension of the controlling shareholder\'s partial share pledge
Xintian Pharmaceutical: Announcement on the controlling shareholder pledging shares and releasing part of the pledge
Xintian Pharmaceutical: Announcement on the completion of cancellation of some repurchased shares and changes in shares
Xintian Pharmaceutical: Announcement on the extension of the controlling shareholder\'s partial share pledge
Guiyang Xintian Pharmaceutical: Announcement on holding an investor briefing on the termination of the issuance of shares for the acquisition of assets and related-party transactions.
Guiyang Xintian Pharmaceutical: Announcement on Termination of Issuing Shares to Purchase Assets and Related Transactions
Guiyang Xintian Pharmaceutical: Announcement on the progress of issuing shares to purchase assets and related trades.
Guiyang Xintian Pharmaceutical: Announcement on Pledge and Extension of Part of Shares of Controlling Shareholders.
Guiyang Xintian Pharmaceutical: Announcement Regarding Change of the Purpose of Repurchasing Shares and Cancellation of Repurchased Shares
Guiyang Xintian Pharmaceutical: Announcement of the implementation of equity distribution in 2023.
Guiyang Xintian Pharmaceutical: Announcement regarding the completion of the cancellation of a portion of restricted share buyback under the 2021 Restricted Stock Incentive Plan.
Guiyang Xintian Pharmaceutical: Announcement on the progress of issuing shares to purchase assets and related trades.
Guiyang Xintian Pharmaceutical: Announcement on the progress of issuing shares to purchase assets and related transactions
Guiyang Xintian Pharmaceutical: Announcement on the results of continuing share repurchases and changes in shares
Xintian Pharmaceutical: Notice on the repurchase and cancellation of some restricted stocks that have been granted but the sales restrictions have not yet been lifted
Xintian Pharmaceutical: Announcement on the 2023 Profit Distribution Plan
Xintian Pharmaceutical: Legal Opinions of Beijing Deheng Law Firm on matters relating to the repurchase and cancellation of some restricted stocks in the Company's 2021 Restricted Stock Incentive Plan
No Data